| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
|
Eur J Pharmacol
|
2006
|
1.57
|
|
2
|
Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
|
Neurobiol Dis
|
2008
|
1.38
|
|
3
|
Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
|
Neurosci Lett
|
2006
|
1.38
|
|
4
|
Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.
|
Antioxid Redox Signal
|
2006
|
1.37
|
|
5
|
Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.
|
Antioxid Redox Signal
|
2012
|
1.24
|
|
6
|
An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach.
|
J Neurosci Res
|
2007
|
1.23
|
|
7
|
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
|
Brain Res
|
2007
|
1.21
|
|
8
|
Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.
|
Free Radic Biol Med
|
2012
|
1.18
|
|
9
|
Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
|
Acta Neuropathol
|
2009
|
1.09
|
|
10
|
Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease.
|
Brain Res
|
2010
|
1.05
|
|
11
|
Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease.
|
Antioxid Redox Signal
|
2010
|
1.04
|
|
12
|
Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study.
|
J Cell Mol Med
|
2007
|
1.02
|
|
13
|
Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.
|
J Proteomics
|
2011
|
1.01
|
|
14
|
In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders.
|
Neurochem Int
|
2005
|
0.98
|
|
15
|
Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
|
J Proteome Res
|
2009
|
0.96
|
|
16
|
Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.
|
Free Radic Biol Med
|
2012
|
0.95
|
|
17
|
Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
|
J Alzheimers Dis
|
2011
|
0.93
|
|
18
|
Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues.
|
PLoS One
|
2012
|
0.93
|
|
19
|
Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis.
|
Neurochem Res
|
2009
|
0.91
|
|
20
|
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.
|
Biochim Biophys Acta
|
2011
|
0.90
|
|
21
|
Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.
|
Biochim Biophys Acta
|
2013
|
0.89
|
|
22
|
Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.
|
Antioxid Redox Signal
|
2012
|
0.88
|
|
23
|
Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2005
|
0.87
|
|
24
|
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.
|
PLoS One
|
2013
|
0.87
|
|
25
|
Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease.
|
Neurotox Res
|
2011
|
0.87
|
|
26
|
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
|
J Neurochem
|
2015
|
0.87
|
|
27
|
Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.
|
Proteomics Clin Appl
|
2014
|
0.86
|
|
28
|
Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro.
|
Neurosci Lett
|
2012
|
0.86
|
|
29
|
In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state.
|
J Neurochem
|
2007
|
0.85
|
|
30
|
Serum proteomics in patients with diagnosis of abdominal aortic aneurysm.
|
Cardiovasc Pathol
|
2011
|
0.85
|
|
31
|
Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1.
|
Int J Biochem Cell Biol
|
2005
|
0.84
|
|
32
|
The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
|
J Neurosci Res
|
2010
|
0.82
|
|
33
|
Modulation of apoptosis and improved redox metabolism with the use of a new antioxidant formula.
|
Biochem Pharmacol
|
2002
|
0.82
|
|
34
|
Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits.
|
Biochim Biophys Acta
|
2011
|
0.82
|
|
35
|
Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
|
Expert Rev Neurother
|
2014
|
0.81
|
|
36
|
UVB irradiation down-regulates HPV-16 RNA expression: implications for malignant progression of transformed cells.
|
Virus Res
|
2007
|
0.81
|
|
37
|
HO-1/BVR-a system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease.
|
J Alzheimers Dis
|
2012
|
0.81
|
|
38
|
Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B.
|
Antioxid Redox Signal
|
2012
|
0.81
|
|
39
|
The identification of protein biomarkers for oxidative stress in Down syndrome.
|
Expert Rev Proteomics
|
2011
|
0.81
|
|
40
|
Heme oxygenase and cyclooxygenase in the central nervous system: a functional interplay.
|
J Neurosci Res
|
2006
|
0.81
|
|
41
|
The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.
|
Clin Ther
|
2007
|
0.81
|
|
42
|
Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study.
|
Free Radic Biol Med
|
2013
|
0.80
|
|
43
|
Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells.
|
Biochem Pharmacol
|
2002
|
0.80
|
|
44
|
Proteomics identification of oxidatively modified proteins in brain.
|
Methods Mol Biol
|
2009
|
0.80
|
|
45
|
In vivo protection of synaptosomes from oxidative stress mediated by Fe2+/H2O2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate.
|
Free Radic Biol Med
|
2005
|
0.79
|
|
46
|
Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion.
|
J Neurochem
|
2012
|
0.79
|
|
47
|
Lack of p53 affects the expression of several brain mitochondrial proteins: insights from proteomics into important pathways regulated by p53.
|
PLoS One
|
2012
|
0.79
|
|
48
|
Involvement of Stat3 in mouse brain development and sexual dimorphism: a proteomics approach.
|
Brain Res
|
2010
|
0.79
|
|
49
|
Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancer.
|
Expert Rev Proteomics
|
2013
|
0.79
|
|
50
|
Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity.
|
J Exp Clin Cancer Res
|
2009
|
0.77
|
|
51
|
Ectopic deposition of melanin pigments as detoxifying mechanism: a paradigm for basal nuclei pigmentation.
|
Biochem Biophys Res Commun
|
2004
|
0.77
|
|
52
|
Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's Syndrome.
|
Neurodegener Dis
|
2015
|
0.76
|
|
53
|
Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.
|
Curr Alzheimer Res
|
2016
|
0.76
|
|
54
|
Redox Proteomics in Human Biofluids: Sample Preparation, Separation and Immunochemical Tagging for Analysis of Protein Oxidation.
|
Methods Mol Biol
|
2016
|
0.75
|